Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sachtleben is a historic German chemical company specializing in the production of high-purity white pigments and functional additives, most notably titanium dioxide and barium sulfate. Within the life sciences and healthcare industries, the company is recognized for its medical-grade barium sulfate, which serves as a critical radiopaque filler for medical devices, dental materials, and X-ray contrast media. Originally founded in 1878, Sachtleben was acquired by Rockwood Holdings and later by Huntsman Corporation in 2014. The business was subsequently spun off and integrated into Venator Materials PLC, where its technologies continue to support pharmaceutical packaging and diagnostic applications. The company's products are essential for enhancing the visibility of medical implants and instruments under fluoroscopy and X-ray imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sachtleben.